AMNEAL PHARMACEUTICALS, INC. Long-term Debt and Lease Obligation, Current
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Long-term Debt and Lease Obligation, Current of $44.23 million as of 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current
us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent · last filed 2021-03-01
- 2020-12-31: Long-term Debt and Lease Obligation, Current $44.23M.
- 2020-09-30: Long-term Debt and Lease Obligation, Current $29.78M.
- 2020-06-30: Long-term Debt and Lease Obligation, Current $29.76M.
- 2020-03-31: Long-term Debt and Lease Obligation, Current $29.74M.
| Period end | Long-term Debt and Lease Obligation, Current | Long-term Debt and Lease Obligation, Current as first filed |
|---|---|---|
| 2020-12-31 | $44.23M 10-K · filed 2021-03-01 | |
| 2020-09-30 | $29.78M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $29.76M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $29.74M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $21.48M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $21.47M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $21.45M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $21.45M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $21.45M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $121.69M 10-Q · filed 2018-11-07 | |
| 2017-12-31 | $89.17M 10-K · filed 2019-03-01 | $89.48M 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |